The NPAC-LSD2 complex in nucleosome demethylation
- PMID: 37748839
- DOI: 10.1016/bs.enz.2023.03.003
The NPAC-LSD2 complex in nucleosome demethylation
Abstract
NPAC is a transcriptional co-activator widely associated with the H3K36me3 epigenetic marks present in the gene bodies. NPAC plays a fundamental role in RNA polymerase progression, and its depletion downregulates gene transcription. In this chapter, we review the current knowledge on the functional and structural features of this multi-domain protein. NPAC (also named GLYR1 or NP60) contains a PWWP motif, a chromatin binder and epigenetic reader that is proposed to weaken the DNA-histone contacts facilitating polymerase passage through the nucleosomes. The C-terminus of NPAC is a catalytically inactive dehydrogenase domain that forms a stable and rigid tetramer acting as an oligomerization module for the formation of co-transcriptional multimeric complexes. The PWWP and dehydrogenase domains are connected by a long, mostly disordered, linker that comprises putative sites for protein and DNA interactions. A short dodecapeptide sequence (residues 214-225) forms the binding site for LSD2, a flavin-dependent lysine-specific histone demethylase. This stretch of residues binds on the surface of LSD2 and facilitates the capture and processing of the H3 tail in the nucleosome context, thus promoting the H3K4me1/2 epigenetic mark removal. LSD2 is associated with other two chromatin modifiers, G9a and NSD3. The LSD2-G9a-NSD3 complex modifies the pattern of the post translational modifications deposited on histones, thus converting the relaxed chromatin into a transcriptionally refractory state after the RNA polymerase passage. NPAC is a scaffolding factor that organizes and coordinates the epigenetic activities required for optimal transcription elongation.
Keywords: Chromatin; Epigenetic mark; LSD2; NPAC; Transcriptional elongation.
Copyright © 2023 Elsevier Inc. All rights reserved.
Similar articles
-
LSD2 Is an Epigenetic Player in Multiple Types of Cancer and Beyond.Biomolecules. 2024 May 3;14(5):553. doi: 10.3390/biom14050553. Biomolecules. 2024. PMID: 38785960 Free PMC article. Review.
-
A Tail-Based Mechanism Drives Nucleosome Demethylation by the LSD2/NPAC Multimeric Complex.Cell Rep. 2019 Apr 9;27(2):387-399.e7. doi: 10.1016/j.celrep.2019.03.061. Cell Rep. 2019. PMID: 30970244
-
LSD2/KDM1B and its cofactor NPAC/GLYR1 endow a structural and molecular model for regulation of H3K4 demethylation.Mol Cell. 2013 Feb 7;49(3):558-70. doi: 10.1016/j.molcel.2012.11.019. Epub 2012 Dec 20. Mol Cell. 2013. PMID: 23260659 Free PMC article.
-
Evaluation of phenylcyclopropylamine compounds by enzymatic assay of lysine-specific demethylase 2 in the presence of NPAC peptide.Bioorg Med Chem Lett. 2016 Feb 15;26(4):1193-5. doi: 10.1016/j.bmcl.2016.01.036. Epub 2016 Jan 16. Bioorg Med Chem Lett. 2016. PMID: 26794039
-
The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update.Biomolecules. 2022 Mar 17;12(3):462. doi: 10.3390/biom12030462. Biomolecules. 2022. PMID: 35327654 Free PMC article. Review.
Cited by
-
LSD2 Is an Epigenetic Player in Multiple Types of Cancer and Beyond.Biomolecules. 2024 May 3;14(5):553. doi: 10.3390/biom14050553. Biomolecules. 2024. PMID: 38785960 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous